Agilent is recognized as a worldwide leader in the design and manufacturing of high quality microplates for biological research and drug discovery. Customers include academic and government institutions, pharmaceutical and biotech organizations, as well as OEM manufacturers of assay kits and laboratory instrument suppliers.
Agilent’s beginnings in microplates dates to 1984, when Innovative Microplates was founded. Innovative Microplates was acquired in 2004 as a division of Seahorse Bioscience. Agilent acquired Seahorse Bioscience in 2016.
Agilent Technologies, Inc. is a U.S. company headquartered in Santa Clara, CA. Our microplates design engineering and production facilities are in Chicopee, MA.